AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Anticoagulants Market Outlook 2019-2023, with Profiles of Key Players: Bayer, BMS/Pfizer, Boehringher Ingelheim, and Daiichi Sankyo - ResearchAndMarkets.com

May 7, 2019

DUBLIN--(BUSINESS WIRE)--May 7, 2019--The “Global Anticoagulants Market: Size, Trends & Forecasts (2019-2023 Edition)” report has been added to ResearchAndMarkets.com’s offering.

Global Anticoagulants Market (2019-2023 Edition) provides an in-depth analysis of the global anticoagulants market with description of market size and growth. The analysis includes market share by segment, and by products.

The report also provides an analysis of injectable and oral anticoagulants available in the market. Details of Lovenox, Arixtra, Xarelto, Eliquis, Pradaxa and Savaysa has been provided in the report in terms of their global sales.

A brief analysis of the US anticoagulants market has also been provided in terms of value and sales of top four oral anticoagulant drugs in the region.

Furthermore, the report also assesses the key opportunities available in the market and outlines the market dynamics that are and will be accountable for growth of the industry. Growth of the global anticoagulants market has also been forecasted for the period 2019-2023, taking into consideration previous growth outlines, growth drivers and the existing and forthcoming trends.

Market Insights

The global anticoagulants market has increased over the years and is expected to grow in the next four years i.e. 2019-2023, particularly due to development of novel oral anticoagulants (NOACs).

The global anticoagulants market is supported by various growth drivers such as growing aging population, rising prevalence of coagulant disorders, increasing demand for NOACs, rising awareness about anticoagulants, etc.

Yet, the market faces some challenges which are obstructing the growth of the market. Some of the challenges are stringent regulations from regulatory bodies, high cost of oral anticoagulants, major side-effects associated with the drugs, etc.

Bayer, BMS/Pfizer, Boehringher Ingelheim and Daiichi Sankyo are some of the key players operating in the global anticoagulants market, whose company profiling has been done in the report. This segment summarizes business overview, financial overview and the business strategies of the companies.

Key Topics Covered

1. Executive Summary

2. Introduction

2.1 Overview of Anticoagulants

2.1.1 Types of Anticoagulants

2.1.2 Novel Oral Anticoagulants

3. Global Market Analysis

3.1 Global Anticoagulants Market Analysis

3.1.1 Global Anticoagulants Market by Value

3.1.2 Global Anticoagulants Market by Countries (The US and Rest of the World)

3.1.3 Global Anticoagulants Market Share by Segment

3.1.4 Global Anticoagulants Market Share by Products

4. Global Anticoagulants Product Analysis

4.1 Oral Anticoagulants Product Analysis

4.1.1 Global Oral Anticoagulants Market by Value

4.1.2 Global Xarelto Market by Value

4.1.3 Global Xarelto Market Value by Region (North America and Rest of the World)

4.1.4 Global Eliquis Market by Value

4.1.5 Global Pradaxa Market by Value

4.1.6 Global Savaysa Market by Value

4.2 Injectable Anticoagulants Product Analysis

4.2.1 Global Lovenox Market by Value

4.2.2 Global Arixtra Market by Value

5. Region/Country Analysis

5.1 The US Anticoagulants Market Analysis

5.1.1 The US Anticoagulants Market by Value

5.1.2 The US Anticoagulants Market by Products

5.1.3 The US Xarelto Market by Value

5.1.4 The US Eliquis Market by Value

5.1.5 The US Pradaxa Market by Value

5.1.6 The US Savaysa Market by Value

6. Competitive Landscape

6.1 Global Anticoagulants Market Players by Product Comparison

7. Company Profiles

7.1 Bayer Group

7.1.1 Business Overview

7.1.2 Financial Overview

7.1.3 Business Strategy

7.2 BMS/Pfizer

7.3 Boehringher Ingelheim

7.4 Daiichi Sankyo

For more information about this report visit https://www.researchandmarkets.com/r/4xhkrz

View source version on businesswire.com:https://www.businesswire.com/news/home/20190507005674/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/07/2019 09:53 AM/DISC: 05/07/2019 09:53 AM

http://www.businesswire.com/news/home/20190507005674/en

All contents © copyright 2019 The Associated Press. All rights reserved.